Compare HHS & CCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HHS | CCM |
|---|---|---|
| Founded | 1923 | 1997 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Advertising | Medical/Nursing Services |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.7M | 19.0M |
| IPO Year | 1994 | 2009 |
| Metric | HHS | CCM |
|---|---|---|
| Price | $4.24 | $4.77 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 9.0K | ★ 46.0K |
| Earning Date | 05-14-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 97.35 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $159,570,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.00 | $3.18 |
| 52 Week High | $4.32 | $6.98 |
| Indicator | HHS | CCM |
|---|---|---|
| Relative Strength Index (RSI) | 85.20 | 51.40 |
| Support Level | $2.70 | $4.41 |
| Resistance Level | $4.32 | $5.52 |
| Average True Range (ATR) | 0.20 | 0.60 |
| MACD | 0.16 | 0.03 |
| Stochastic Oscillator | 90.60 | 39.63 |
Harte-Hanks Inc is a customer experience company. The company operates three business segments: Revenue Solutions; Customer Care; and Fulfillment & Logistics Services. It derives maximum revenue from Fulfillment & Logistics Services segment. The Fulfillment & Logistics Services segment includes printing, lettershop, advanced mail optimization (including commingling services), logistics and transportation optimization, monitoring and tracking, to support traditional and specialized mailings. The company has a geographic presence in the United States and Other countries. The majority of the revenue is earned from the United States.
Concord Medical Services Holdings Ltd operates radiotherapy and diagnostic imaging centers in China. The company is involved in the leasing of radiotherapy and diagnostic imaging equipment, provision of management services to hospitals, medicine sales, and provision of premium cancer and proton treatment services. The company has two operating segments, including network and hospital. Geographically, the company derives revenue from PRC.